Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04630171 · ClinicalTrials.gov registry record · NA
VerTouch Device: A Prospective Randomized Controlled Trial
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT04630171 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 86 participants.
The verdict
NCT04630171, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
This study will compare the VerTouch device to palpation and ultrasound (US) techniques used to identifying the anatomic landmarks and optimal location for neuraxial access. This trial of the VerTouch device will be compared to the gold standard of palpation and the commonly cited US techniques.
Interventions
- DEVICE Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure
- DEVICE Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure
- OTHER Group #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04630171
The ClinicalTrials.gov registry entry for NCT04630171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure is the first listed.
NCT04630171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04630171 about?
NCT04630171 is a clinical study titled "VerTouch Device: A Prospective Randomized Controlled Trial". This study will compare the VerTouch device to palpation and ultrasound (US) techniques used to identifying the anatomic landmarks and optimal location for neuraxial access. This trial of the VerTouch device will be compared to the gold standard of palpation and the commonly cited US techniques.
What is the current status of trial NCT04630171?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2021-01-01. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT04630171?
The interventions under investigation include: Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure (DEVICE), Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure (DEVICE), Group #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure (OTHER).
Who is sponsoring clinical trial NCT04630171?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.